HITI vs. DRTS, OM, TRVI, IPSC, ZVRA, ACRV, FENC, OMER, OBIO, and OPT
Should you be buying High Tide stock or one of its competitors? The main competitors of High Tide include Alpha Tau Medical (DRTS), Outset Medical (OM), Trevi Therapeutics (TRVI), Century Therapeutics (IPSC), Zevra Therapeutics (ZVRA), Acrivon Therapeutics (ACRV), Fennec Pharmaceuticals (FENC), Omeros (OMER), Orchestra BioMed (OBIO), and Opthea (OPT). These companies are all part of the "medical" sector.
Alpha Tau Medical (NASDAQ:DRTS) and High Tide (NASDAQ:HITI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability.
Alpha Tau Medical has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Comparatively, High Tide has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.
Alpha Tau Medical has a net margin of 0.00% compared to Alpha Tau Medical's net margin of -7.46%. Alpha Tau Medical's return on equity of -2.03% beat High Tide's return on equity.
In the previous week, Alpha Tau Medical had 12 more articles in the media than High Tide. MarketBeat recorded 16 mentions for Alpha Tau Medical and 4 mentions for High Tide. High Tide's average media sentiment score of 0.91 beat Alpha Tau Medical's score of 0.87 indicating that Alpha Tau Medical is being referred to more favorably in the media.
Alpha Tau Medical received 4 more outperform votes than High Tide when rated by MarketBeat users. Likewise, 61.90% of users gave Alpha Tau Medical an outperform vote while only 39.13% of users gave High Tide an outperform vote.
2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 4.5% of High Tide shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 12.4% of High Tide shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Alpha Tau Medical currently has a consensus target price of $12.00, indicating a potential upside of 385.83%. High Tide has a consensus target price of $4.50, indicating a potential upside of 89.08%. Given High Tide's higher possible upside, analysts clearly believe Alpha Tau Medical is more favorable than High Tide.
High Tide has higher revenue and earnings than Alpha Tau Medical. High Tide is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Alpha Tau Medical beats High Tide on 10 of the 16 factors compared between the two stocks.
Get High Tide News Delivered to You Automatically
Sign up to receive the latest news and ratings for HITI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HITI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
High Tide Competitors List
Related Companies and Tools
